(Q37968929)

26 August 2017

title

Medulloblasoma: challenges for effective immunotherapy (English)

1 reference

26 August 2017

1 reference

1

Adam M Sonabend

1 reference

26 August 2017

Alfred T Ogden

2

1 reference

26 August 2017

Lisa M Maier

3

1 reference

26 August 2017

David E Anderson

4

1 reference

26 August 2017

Peter Canoll

5

1 reference

26 August 2017

Jeffrey N Bruce

6

1 reference

26 August 2017

Richard C E Anderson

7

1 reference

26 August 2017

publication date

16 December 2011

1 reference

Journal of Neuro-Oncology

26 August 2017

published in

1 reference

26 August 2017

volume

108

1 reference

26 August 2017

issue

1

1 reference

26 August 2017

page(s)

1-10

1 reference

https://scigraph.springernature.com/pub.10.1007/s11060-011-0776-1

26 August 2017

exact match

0 references

cites work

Clinical, histopathologic, and molecular markers of prognosis: toward a new disease risk stratification system for medulloblastoma

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

Incidence and trends in pediatric malignancies medulloblastoma/primitive neuroectodermal tumor: a SEER update. Surveillance Epidemiology and End Results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: The International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

Genomics of medulloblastoma: from Giemsa-banding to next-generation sequencing in 20 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

Targeting medulloblastoma: small-molecule inhibitors of the Sonic Hedgehog pathway as potential cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

Suppression of the Shh pathway using a small molecule inhibitor eliminates medulloblastoma in Ptc1(+/-)p53(-/-) mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

Small-molecule inhibitors of phosphatidylinositol 3-kinase/Akt signaling inhibit Wnt/beta-catenin pathway cross-talk and suppress medulloblastoma growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

Natural innate and adaptive immunity to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

How does Epstein-Barr virus (EBV) complement the activation of Myc in the pathogenesis of Burkitt's lymphoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

Contribution of the Epstein Barr virus to the molecular pathogenesis of Hodgkin lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

Adaptive immunity maintains occult cancer in an equilibrium state

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

Targeting epidermal growth factor receptor variant III: a novel strategy for the therapy of malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

Immunobiology of paediatric intracranial tumours a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

Malignant glioma biology: role for TGF-beta in growth, motility, angiogenesis, and immune escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

Inhibition of lymphocyte function by glioblastoma-derived transforming growth factor beta 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

Prostaglandin E2 as an immunomodulating factor released in vitro by human glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

Induction of macrophagic prostaglandin E2 synthesis by glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

Lack of B7 expression, not human leukocyte antigen expression, facilitates immune evasion by human malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

Augmentation of MHC class I antigen presentation via heat shock protein expression by hyperthermia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

Cellular immunity and immunotherapy of brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

Changes in the immunologic phenotype of human malignant glioma cells after passaging in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

Hide-and-seek in the brain: a role for HLA-G mediating immune privilege for glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

Both CD133+ and CD133- medulloblastoma cell lines express ligands for triggering NK receptors and are susceptible to NK-mediated cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

Microglial/macrophage expression of interleukin 10 in human glioblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

Astrocytic regulation of human monocytic/microglial activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

Prolongation of survival following depletion of CD4+CD25+ regulatory T cells in mice with experimental brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

An increase in CD4+CD25+FOXP3+ regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

CD4+ CD25+ FoxP3+ T-cell infiltration and heme oxygenase-1 expression correlate with tumor grade in human gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

Stimulation of TLR9 with CpG ODN enhances apoptosis of glioma and prolongs the survival of mice with experimental brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

Systemic anti-CD25 monoclonal antibody administration safely enhances immunity in murine glioma without eliminating regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

Profiling of CD4+, CD8+, and CD4+CD25+CD45RO+FoxP3+ T cells in patients with malignant glioma reveals differential expression of the immunologic transcriptome compared with T cells from healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

Recurrent medulloblastoma following pediatric double-lung transplant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

The role of T-helper 17 (Th17) cells in patients with medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

HLA class I antigen abnormalities and immune escape by malignant cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

Functional deficiencies of components of the MHC class I antigen pathway in human tumors of epithelial origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

MHC class I gene expression and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

Molecular characteristics of non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

Down-regulation of HLA class I antigen-processing molecules in malignant melanoma: association with disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

Downregulation of major histocompatibility complex antigens in invading glioma cells: stealth invasion of the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

Human leukocyte antigen and antigen processing machinery component defects in astrocytic tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

Is downregulation of MHC class I antigen expression in human non-small cell lung cancer associated with prolonged survival?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

Expression and functional analysis of human leukocyte antigen class I antigen-processing machinery in medulloblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

A novel role of HLA class I in the pathology of medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

Expression of MAGE and GAGE genes in medulloblastoma and modulation of resistance to chemotherapy. Laboratory investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

Clinical Benefit of Allogeneic Melanoma Cell Lysate-Pulsed Autologous Dendritic Cell Vaccine in MAGE-Positive Colorectal Cancer Patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

Mage-b vaccine delivered by recombinant Listeria monocytogenes is highly effective against breast cancer metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

Prevention of metastases with a Mage-b DNA vaccine in a mouse breast tumor model: potential for breast cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

Vaccine-induced CD4+ T cell responses to MAGE-3 protein in lung cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

An epidermal growth factor receptor variant III-targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

Novel tumor antigens identified by autologous antibody screening of childhood medulloblastoma cDNA libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

Regression of experimental medulloblastoma following transfer of HER2-specific T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

Current immunotherapeutic strategies for central nervous system tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

Dendritic cell vaccines for brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

Heat-shock protein vaccines as active immunotherapy against human gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

An adoptive immunotherapy of patients with medulloblastoma by lymphokine-activated killer cells (LAK).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

Immunological fluctuations during intrathecal immunotherapy in three patients affected by CNS tumours disseminating via CSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

Adoptive immunotherapy using lymphokine-activated killer (LAK) cells and interleukin-2 for recurrent malignant primary brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

In vitro cytolysis of primitive neuroectodermal tumors of the posterior fossa (medulloblastoma) by lymphokine-activated killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

Lymphokine activated killer cells from umbilical cord blood show higher antitumor effect against anaplastic astrocytoma cell line (U87) and medulloblastoma cell line (TE671) than lymphokine activated killer cells from peripheral blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0776-1

Immunobiology of primary CNS tumors in infancy and childhood. B- and T-cell dependent immunity and cytotoxicity and cell kinetic evaluation.

21 January 2018

1 reference

12 December 2020

Fatal melanoma transferred in a donated kidney 16 years after melanoma surgery

1 reference

12 December 2020

Treatment of a patient by vaccination with autologous dendritic cells pulsed with allogeneic major histocompatibility complex class I-matched tumor peptides. Case Report

1 reference

12 December 2020

Transforming growth factor-beta 1, -beta 2, and -beta 3 secreted by a human glioblastoma cell line. Identification of small and different forms of large latent complexes

1 reference

12 December 2020

Total loss of MHC class I is an independent indicator of good prognosis in breast cancer

1 reference

12 December 2020

Transplant tumor registry: donor related malignancies

1 reference

12 December 2020

In vitro reversal of depressed T-lymphocyte function in the peripheral blood of brain tumor patients

1 reference

12 December 2020

Cancer-testis (CT) antigen expression in medulloblastoma.

1 reference

12 December 2020

HLA class I antigen down-regulation in primary ovary carcinoma lesions: association with disease stage.

1 reference

12 December 2020

Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: a Children's Cancer Group study

1 reference

12 December 2020

Identification and characterization of interleukin-13 receptor in human medulloblastoma and targeting these receptors with interleukin-13-pseudomonas exotoxin fusion protein.

1 reference

12 December 2020

Immunophenotypic characterization of infiltrating polynuclear and mononuclear cells in childhood brain tumors

1 reference

12 December 2020

Depressed T lymphocyte function in brain tumor patients: Monocytes as suppressor cells

1 reference

12 December 2020

2007 World Health Organization classification of tumours of the central nervous system

1 reference

12 December 2020

[Studies of children with acute lymphoblastic leukemia (ALL) who relapsed. Relationship of site of relapse, time and prognosis]

1 reference

12 December 2020

The role of regulatory T cells in malignant glioma.

1 reference

12 December 2020

Association of HLA class I and class II antigen expression and mortality in uveal melanoma

1 reference

12 December 2020

CD4+FoxP3+ regulatory T cells gradually accumulate in gliomas during tumor growth and efficiently suppress antiglioma immune responses in vivo.

1 reference

12 December 2020

Toll-like receptor triggered dendritic cell maturation and IL-12 secretion are necessary to overcome T-cell inhibition by glioma-associated TGF-beta2.

1 reference

12 December 2020

The role of human papilloma virus (HPV) in the aetiology of cervical cancer

1 reference

12 December 2020

The failure of current immunotherapy for malignant glioma. Tumor-derived TGF-beta, T-cell apoptosis, and the immune privilege of the brain

1 reference

12 December 2020

Characteristic immunological responses to an experimental mouse brain tumor

1 reference

12 December 2020

10.1007/S11060-011-0776-1

Identifiers

DOI

1 reference

26 August 2017

1 reference